Torrent Pharmaceuticals is currently trading at Rs. 3481.55, up by 46.85 points or 1.36% from its previous closing of Rs. 3434.70 on the BSE.
The scrip opened at Rs. 3445.05 and has touched a high and low of Rs. 3574.00 and Rs. 3445.05 respectively. So far 11472 shares were traded on the counter.
The BSE group 'A' stock of face value Rs. 5 has touched a 52 week high of Rs. 3574.00 on 30-Aug-2024 and a 52 week low of Rs. 1771.35 on 01-Sep-2023.
Last one week high and low of the scrip stood at Rs. 3574.00 and Rs. 3269.65 respectively. The current market cap of the company is Rs. 118146.23 crore.
The promoters holding in the company stood at 71.25%, while Institutions and Non-Institutions held 21.49% and 7.26% respectively.
Torrent Pharmaceuticals has received Establishment Inspection Report (EIR) from the United States Food and Drug Administration (USFDA) with Voluntary Action Indicated (VAI) classification for its manufacturing facility located at Indrad, Gujarat. The inspection has now been successfully closed by the USFDA. The inspection was conducted from June 03, 2024 to June 12, 2024.
Torrent Pharmaceuticals is flagship company of the Torrent group, a leader in cardiovascular and central nervous system segments. It also has presence in gastro-intestinal, diabetology, anti-infective and pain management segments.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1808.50 |
Dr. Reddys Lab | 1342.45 |
Cipla | 1472.45 |
Lupin | 2147.55 |
Zydus Lifesciences | 973.90 |
View more.. |